Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-08

Clinical Trial Update: The Impact of a Human Breast Milk Supplement on Epigenetic and Cellular Markers [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a human breast milk supplement and its effects on epigenetic and cellular markers in aging.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Human breast milk supplement

Snippet

Sponsor: TruDiagnostic | Conditions: Aging | Phase 2 | Status: UNKNOWN